Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Equivalence of Permethrin Cream 5% vs Elimite™ in Scabies
NCT02572986Phase 3Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Sep 2015
- Primary completion
- Jun 2016
- Modality
- Allosteric Modulators
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of permethrin in scabies (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Proportion of patients with therapeutic cure (parasitological cure plus clinical cure) at Day 28. Started Sep 2015; status: completed.
02
Drugs
permethrin
03
Conditions
scabies
Beyond the preview
Go deeper on NCT02572986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02572986.